Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke

Abstract Background and purpose We performed a retrospective analysis of the “Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS‐China)” registry to explore the benefit and risk of intravenous thrombolysis (IVT) followed by intravenous heparin (IVH) in acute ischemic str...

Full description

Bibliographic Details
Main Authors: Xu Tong, Yibin Cao, Wenzhi Wang, David Wang, Yongjun Wang, Yilong Wang, the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) Investigators
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.1776
_version_ 1828529618994331648
author Xu Tong
Yibin Cao
Wenzhi Wang
David Wang
Yongjun Wang
Yilong Wang
the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) Investigators
author_facet Xu Tong
Yibin Cao
Wenzhi Wang
David Wang
Yongjun Wang
Yilong Wang
the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) Investigators
author_sort Xu Tong
collection DOAJ
description Abstract Background and purpose We performed a retrospective analysis of the “Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS‐China)” registry to explore the benefit and risk of intravenous thrombolysis (IVT) followed by intravenous heparin (IVH) in acute ischemic stroke (AIS) patients. Methods In the TIMS‐China database, the patients who received IVH immediately after IVT (Early IVH group) and those who initiated antithrombotic therapy (ATT) until 24 hr after IVT (Standard ATT group) were screened for this comparison. Propensity score (PS) matching was performed between both groups. The logistic regression analysis was performed in the matched population to compare all the efficacy and safety outcomes. Results Of 1,437 patients in this study, 119 received early IVH and 1,318 cases initiated standard ATT. After PS matching (1:2), 117 pairs were identified. The early IVH group had higher proportions of neurological improvement at 24 hr (OR = 2.24, 95% CI = 1.42–3.53) and 7 days (OR = 1.92, 95% CI = 1.22–3.03), better chance of excellent recovery (OR = 1.69, 95% CI = 1.07–2.67) and functional independence (OR = 1.77, 95% CI = 1.13–2.78) at 90 days, and a lower 90‐day mortality (OR = 0.44, 95% CI = 0.21–0.92) than standard ATT group. Additionally, early IVH did not increase the risk of symptomatic intracranial hemorrhage (OR = 0.92, 95% CI = 0.34–2.48). Conclusions IVH immediately after thrombolysis seems to be safe and potentially more effective as compared with standard ATT delay of 24 hr for a subset of AIS patients.
first_indexed 2024-12-11T22:11:32Z
format Article
id doaj.art-e64c5e2d17de4e7eaee142f0d8cf82fb
institution Directory Open Access Journal
issn 2162-3279
language English
last_indexed 2024-12-11T22:11:32Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj.art-e64c5e2d17de4e7eaee142f0d8cf82fb2022-12-22T00:48:46ZengWileyBrain and Behavior2162-32792020-10-011010n/an/a10.1002/brb3.1776Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic strokeXu Tong0Yibin Cao1Wenzhi Wang2David Wang3Yongjun Wang4Yilong Wang5the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) InvestigatorsDepartment of Interventional Neuroradiology Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurology Tangshan Gongren HospitalHebei Medical University Tangshan ChinaBeijing Neurosurgical Institute Capital Medical University Beijing ChinaIllinois Neurological Institute Stroke Network Sisters of the Third Order of St Francis Healthcare System University of Illinois College of Medicine Peoria IL USADepartment of Neurology Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurology Beijing Tiantan Hospital Capital Medical University Beijing ChinaAbstract Background and purpose We performed a retrospective analysis of the “Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS‐China)” registry to explore the benefit and risk of intravenous thrombolysis (IVT) followed by intravenous heparin (IVH) in acute ischemic stroke (AIS) patients. Methods In the TIMS‐China database, the patients who received IVH immediately after IVT (Early IVH group) and those who initiated antithrombotic therapy (ATT) until 24 hr after IVT (Standard ATT group) were screened for this comparison. Propensity score (PS) matching was performed between both groups. The logistic regression analysis was performed in the matched population to compare all the efficacy and safety outcomes. Results Of 1,437 patients in this study, 119 received early IVH and 1,318 cases initiated standard ATT. After PS matching (1:2), 117 pairs were identified. The early IVH group had higher proportions of neurological improvement at 24 hr (OR = 2.24, 95% CI = 1.42–3.53) and 7 days (OR = 1.92, 95% CI = 1.22–3.03), better chance of excellent recovery (OR = 1.69, 95% CI = 1.07–2.67) and functional independence (OR = 1.77, 95% CI = 1.13–2.78) at 90 days, and a lower 90‐day mortality (OR = 0.44, 95% CI = 0.21–0.92) than standard ATT group. Additionally, early IVH did not increase the risk of symptomatic intracranial hemorrhage (OR = 0.92, 95% CI = 0.34–2.48). Conclusions IVH immediately after thrombolysis seems to be safe and potentially more effective as compared with standard ATT delay of 24 hr for a subset of AIS patients.https://doi.org/10.1002/brb3.1776anticoagulationheparinischemic strokethrombolysistissue plasminogen activator
spellingShingle Xu Tong
Yibin Cao
Wenzhi Wang
David Wang
Yongjun Wang
Yilong Wang
the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) Investigators
Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
Brain and Behavior
anticoagulation
heparin
ischemic stroke
thrombolysis
tissue plasminogen activator
title Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
title_full Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
title_fullStr Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
title_full_unstemmed Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
title_short Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
title_sort benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
topic anticoagulation
heparin
ischemic stroke
thrombolysis
tissue plasminogen activator
url https://doi.org/10.1002/brb3.1776
work_keys_str_mv AT xutong benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT yibincao benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT wenzhiwang benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT davidwang benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT yongjunwang benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT yilongwang benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke
AT thethrombolysisimplementationmonitorofacuteischemicstrokeinchinatimschinainvestigators benefitandriskofearlyintravenousheparinafterthrombolysisinpatientswithacuteischemicstroke